- Companies
- Avail Medsystems
Avail Medsystems Funding, Investors & Competitors
Avail Medsystems has raised $128M across 3 funding rounds, most recently a $100M Series B in October 2020.
Last Avail Medsystems funding round
$100M
Series B · Oct 2020
Cumulative funding Avail Medsystems raised
$128M
across 3 funding rounds
Key investors in Avail Medsystems
Baidu Ventures
Playground Global
8VC
Lux Capital
Coatue
D1 Capital Partners
Refactor
GRIDS Capital
About Avail Medsystems
Avail Medsystems is a Silicon Valley-headquartered digital surgery platform founded in 2017 that equips procedure rooms with integrated hardware and software. The system supports telepresence for remote expert collaboration and cloud hosting for surgical video capture. Avail enables MedTech firms and hospitals to streamline device training and procedure documentation.
Founded
2017
HQ
Website
Status
Privately held
Customer focus
B2B
Revenue model
Subscription
Avail Medsystems Funding History
Avail Medsystems has raised a total of $128M across 3 funding rounds.
Avail Medsystems' first fundraising round was a $13M Series A in May 2018. The most recent completed round was a $100M Series B in October 2020.
Avail Medsystems funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Oct 2020 | Series B | D1 Capital Partners (lead); 8VC | $100M | Avail Medsystems is a medical technology company developing Procedural Telemedicine technology for operating rooms and procedure rooms, enabling remote access to clinical expertise in specialties like cardiovascular interventions, neurology, electrophysiology, orthopedics, and general surgery. On October 7, 2020, the company raised $100 million in Series B funding led by D1 Capital Partners, with participation from 8VC and existing investors including Lux Capital, Coatue, Sonder Capital, Playground Global, Baidu Ventures, and Refractor Capital. This followed a prior $25 million in Series A and Series A-1 funding. The new capital is intended to expand the Avail System into additional clinical specialties, enhance penetration in existing ones, improve access to medical expertise, reduce time and costs for healthcare facilities, medical device companies, and patients, and accelerate adoption of new medical technologies. D1 Capital Partners highlighted Avail's role in addressing systemic problems in the medical community through innovative solutions, aiming to bring Procedural Telemedicine to hospitals and surgery centers globally. The funding reflects strong investor interest in digital health, as part of a robust Q4 2020 for the sector totaling billions across numerous raises. |
| Mar 2020 | Series A | Coatue (lead); Lux Capital (lead); Sonder Capital (lead); GRIDS Capital; Refactor; Baidu Ventures; Playground Global | $15M | Avail Medsystems is a healthcare technology company that provides real-time collaboration platforms for operating rooms, connecting surgeons to remote medical experts during procedures. The company was founded in 2017 and developed built-for-operating-room audio/visual hardware paired with software enabling remote users to control video views and imaging systems. Avail was later acquired by Mendaera, Inc., which sought to combine the telepresence technology with robotics, real-time imaging, and AI to improve care delivery accessibility. At the time of acquisition, the company had completed multiple funding rounds totaling $125 million from investors including Coatue, Lux Capital, Baidu Ventures, and others. |
| May 2018 | Series A | Baidu Ventures; Playground Global; Sahsen Ventures | $13M | - |
Who has invested in Avail Medsystems?
10 investors have backed Avail Medsystems across its funding rounds, including Baidu Ventures, Playground Global, 8VC, Lux Capital, Coatue and D1 Capital Partners.
Lead investors include D1 Capital Partners, Coatue, Lux Capital and Sonder Capital.
Avail Medsystems Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 2 | Participant | May 2018 | ||
| 2 | Participant | May 2018 | ||
| 1 | Participant | Mar 2020 | ||
| 1 | Lead | Mar 2020 | ||
| 1 | Participant | Oct 2020 | ||
| 1 | Lead | Mar 2020 | ||
| 1 | Participant | Mar 2020 | ||
| 1 | Lead | Oct 2020 | ||
This data is available for Pro users. Sign up to see all 10 Avail Medsystems investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAvail Medsystems Competitors
Avail Medsystems competitors include listed companies like IDEXX Laboratories, GE HealthCare, United Imaging and Glaukos, and private ones like Dental Monitoring and AcuityMD.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $4.3B | $1.5B | $40B | 8.9x | ||
| Publicly listed | $21B | $3.7B | $29B | 1.8x | ||
| Publicly listed | $2.1B | $367M | $12B | 4.8x | ||
| Publicly listed | $507M | ($157M) | $9.5B | 14.6x | ||
| Private | $91M | - | $1B | - | ||
| Private | - | - | $955M | - |
Avail Medsystems Public Comps
Avail Medsystems is still privately-owned, but its public comps include Samsung, Johnson & Johnson, Roche, Thermo Fisher Scientific, Siemens, Abbott, Danaher, Intuitive Surgical, Medtronic and Stryker.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $243B | $67B | 4.4x | 2.4x | 15.8x | 4.4x | |||
| $94B | $40B | 7.2x | 6.8x | 17.0x | 18.3x | |||
| $77B | $26B | 5.0x | 4.9x | 14.6x | 12.4x | |||
| $45B | $11B | 6.3x | 6.0x | 26.8x | 23.6x | |||
| $91B | $15B | 3.0x | 2.9x | 18.1x | 15.7x | |||
| $44B | $12B | 4.6x | 4.2x | 17.4x | 15.8x | |||
| $25B | $6.9B | 7.0x | 6.6x | 24.8x | 21.1x | |||
| $10B | $3.6B | 13.0x | 11.6x | 36.6x | 25.7x | |||
This data is available for Pro users. Sign up to see all Avail Medsystems competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Avail Medsystems
| When was Avail Medsystems founded? | Avail Medsystems was founded in 2017. |
| Where is Avail Medsystems headquartered? | Avail Medsystems is headquartered in San Jose, CA, United States. |
| Is Avail Medsystems publicly listed? | No, Avail Medsystems is a private, VC-backed company. |
| How much funding has Avail Medsystems raised? | Avail Medsystems has raised $128M across 3 funding rounds. |
| What was Avail Medsystems' last funding round? | Avail Medsystems' last funding round was a $100M Series B in October 2020, led by D1 Capital Partners. |
| Who are Avail Medsystems' investors? | Avail Medsystems' investors include Baidu Ventures, Playground Global, GRIDS Capital, Sonder Capital, 8VC, Lux Capital, Refactor, D1 Capital Partners, Sahsen Ventures and Coatue. |
| Which companies are comparable to Avail Medsystems? | Companies comparable to Avail Medsystems include IDEXX Laboratories, GE HealthCare, United Imaging, Glaukos, Dental Monitoring and AcuityMD. |
See companies similar to Avail Medsystems
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




